Mateusz Polak
Mateusz Polak has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Jakub Grandos
St. John of God Brothers Hospitaller Hospital in Lodz, Poland
6 shared publications - Jakub Jonakowski
Nikolay Pirogov Specialized District Hospital in Łódź
5 shared publications - Julia Nowak
Nikolay Pirogov Specialized District Hospital in Łódź
5 shared publications - Mateusz Łaszczych
Central Teaching Hospital of The Medical University of Łódź
5 shared publications - Barbara Bralewska
Central Teaching Hospital of The Medical University of Łódź
4 shared publications - Julia Wykrota
Student Scientific Association, Medical University of Lodz, 90-419 Lodz, Poland
4 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 75467
GLP-1-Based Therapies and Relative Energy Deficiency in Sport Among Physically Active Individuals: Plausible Pathways, Evidence Gaps, and Monitoring Considerations
Background. GLP-1 receptor agonists and related incretin-based therapies reduce appetite, energy intake, and body mass. Their growing use and discussion in sport raise concern about possible interactions with low energy availability, although a direct relationship with Relative Energy Deficiency in Sport (REDs) has not been established. Aim. To evaluate how GLP-1-based therapies may intersect with REDs-relevant pathways in physically active individuals while separating established clinical effects, athlete evidence, and untested inference. Materials and Methods. A structured narrative review used three PubMed/MEDLINE search streams addressing GLP-1 therapies and sport, appetite/body composition/exercise pathways, and REDs or low energy availability. Fifty-five full texts were assessed and the evidence was synthesized thematically. Results. Trials conducted mainly in non-athletic populations show reduced hunger, cravings, and laboratory-measured intake; gastrointestinal effects may further limit food tolerance. Weight loss includes variable reductions in lean-mass indices, but these measures do not establish loss of contractile muscle, strength, or performance. Athlete studies separately associate problematic low energy availability with reproductive, bone, endocrine, injury, and selected performance outcomes. No prospective study has tested progression from GLP-1 exposure to problematic low energy availability and REDs in athletes. Conclusions. GLP-1-based therapy should be considered a potential modifying factor within the REDs framework, not a proven cause. Current evidence supports individualized monitoring of treatment indication, weight trajectory, dietary adequacy, gastrointestinal tolerance, training, recovery, body composition, function, reproductive and bone health, and eating behavior. Athlete-specific prospective studies are required.
- 28 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 77, 75467
Open AccessGLP-1-Based Therapies and Relative Energy Deficiency in Sport Among Physically Active Individuals: Plausible Pathways, Evidence Gaps, and Monitoring Considerations
Background. GLP-1 receptor agonists and related incretin-based therapies reduce appetite, energy intake, and body mass. Their growing use and discussion in sport raise concern about possible interactions with low energy availability, although a direct relationship with Relative Energy Deficiency in Sport (REDs) has not been established. Aim. To evaluate how GLP-1-based therapies may intersect with REDs-relevant pathways in physically active individuals while separating established clinical effects, athlete evidence, and untested inference. Materials and Methods. A structured narrative review used three PubMed/MEDLINE search streams addressing GLP-1 therapies and sport, appetite/body composition/exercise pathways, and REDs or low energy availability. Fifty-five full texts were assessed and the evidence was synthesized thematically. Results. Trials conducted mainly in non-athletic populations show reduced hunger, cravings, and laboratory-measured intake; gastrointestinal effects may further limit food tolerance. Weight loss includes variable reductions in lean-mass indices, but these measures do not establish loss of contractile muscle, strength, or performance. Athlete studies separately associate problematic low energy availability with reproductive, bone, endocrine, injury, and selected performance outcomes. No prospective study has tested progression from GLP-1 exposure to problematic low energy availability and REDs in athletes. Conclusions. GLP-1-based therapy should be considered a potential modifying factor within the REDs framework, not a proven cause. Current evidence supports individualized monitoring of treatment indication, weight trajectory, dietary adequacy, gastrointestinal tolerance, training, recovery, body composition, function, reproductive and bone health, and eating behavior. Athlete-specific prospective studies are required.
- Open Access
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75461
Capsaicin-Related Compounds and Exercise Performance in Resistance and High-Intensity Exercise: A Narrative Review
Background. Capsaicin-related compounds, including capsaicin, capsinoids/capsiate, dihydrocapsiate and phenylcapsaicin, are investigated as potential TRPV1-related ergogenic aids, but human exercise evidence remains heterogeneous. Objective. This structured narrative review summarizes human evidence on capsaicin-related compounds in resistance and high-intensity exercise, focusing on performance, rating of perceived exertion (RPE), fatigue, recovery, delayed-onset muscle soreness (DOMS), and selected physiological or neuromuscular outcomes. Methods. A structured PubMed search was supplemented by targeted compound-specific queries. After deduplication and search refinement, 62 unique records were screened by title and Human studies of oral supplementation in resistance, high-intensity, sprint, intermittent, CrossFit-type and recovery-related exercise contexts were prioritized. Findings. Current evidence suggests protocol-specific rather than universal ergogenic effects. Capsaicin showed selected benefits in small male crossover trials involving resistance exercise and high-intensity intermittent exercise, but not in repeated sprinting or continuous high-intensity running. Capsiate and dihydrocapsiate showed mixed findings, with no clear dose-response pattern. Phenylcapsaicin showed preliminary benefits for selected squat, jump, mechanical-performance and soreness-related outcomes, but not consistently for RPE, metabolic markers or whole-session CrossFit Workout-of-the-Day performance. Conclusions. Capsaicin-related compounds may have compound- and protocol-specific ergogenic potential, particularly in selected resistance and intermittent high-intensity settings. However, current evidence is limited by small samples, heterogeneous protocols, inconsistent outcomes and limited independent replication. Larger, well-controlled trials are needed before firm practical recommendations can be made.
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75461
Open AccessCapsaicin-Related Compounds and Exercise Performance in Resistance and High-Intensity Exercise: A Narrative Review
Background. Capsaicin-related compounds, including capsaicin, capsinoids/capsiate, dihydrocapsiate and phenylcapsaicin, are investigated as potential TRPV1-related ergogenic aids, but human exercise evidence remains heterogeneous. Objective. This structured narrative review summarizes human evidence on capsaicin-related compounds in resistance and high-intensity exercise, focusing on performance, rating of perceived exertion (RPE), fatigue, recovery, delayed-onset muscle soreness (DOMS), and selected physiological or neuromuscular outcomes. Methods. A structured PubMed search was supplemented by targeted compound-specific queries. After deduplication and search refinement, 62 unique records were screened by title and Human studies of oral supplementation in resistance, high-intensity, sprint, intermittent, CrossFit-type and recovery-related exercise contexts were prioritized. Findings. Current evidence suggests protocol-specific rather than universal ergogenic effects. Capsaicin showed selected benefits in small male crossover trials involving resistance exercise and high-intensity intermittent exercise, but not in repeated sprinting or continuous high-intensity running. Capsiate and dihydrocapsiate showed mixed findings, with no clear dose-response pattern. Phenylcapsaicin showed preliminary benefits for selected squat, jump, mechanical-performance and soreness-related outcomes, but not consistently for RPE, metabolic markers or whole-session CrossFit Workout-of-the-Day performance. Conclusions. Capsaicin-related compounds may have compound- and protocol-specific ergogenic potential, particularly in selected resistance and intermittent high-intensity settings. However, current evidence is limited by small samples, heterogeneous protocols, inconsistent outcomes and limited independent replication. Larger, well-controlled trials are needed before firm practical recommendations can be made.
- Open Access
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75671
Objective Exercise Outcomes During GLP-1 Based Therapy: Distinguishing Cardiorespiratory Fitness from Walking Capacity. A Narrative Review
Background. Glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies can produce substantial weight loss and metabolic benefits. Their effects on objective exercise outcomes are less clear because studies use non-interchangeable endpoints ranging from directly measured oxygen uptake (VO₂) to walking distance. Objective. To summarize objective exercise outcomes during GLP-1-based therapy and separate directly measured cardiorespiratory fitness from changes observed with exercise training and from disease-specific walking capacity. Methods. We searched PubMed and tracked relevant citations up to July 2026. Adult clinical studies reporting at least one objective exercise outcome were grouped by outcome domain. Results. Ten clinical studies were included. In the 193-participant secondary analysis, liraglutide alone did not improve VO₂-derived fitness or physical-performance outcomes. Two smaller trials of exenatide or liraglutide without structured exercise were also neutral. VO₂ improved when structured exercise was included, but comparisons with matched exercise did not establish a clear additive drug effect. Walking outcomes improved most clearly in peripheral artery disease, whereas coronary artery disease and ischemia-focused endpoints were neutral. During substantial weight loss, body-mass-normalized VO₂ may rise partly because body mass in the denominator falls; absolute VO₂, VO₂ normalized to fat-free mass, workload, strength, and body composition therefore require separate interpretation. Conclusions.The meaning of an objective exercise outcome depends on what was measured. Current evidence does not consistently show an independent improvement in directly measured cardiorespiratory fitness with pharmacotherapy alone. Structured exercise remains the best-supported context for improving aerobic fitness. Disease-specific gains in walking capacity should not be interpreted as generalized cardiorespiratory-fitness gains.
- 27 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 75671
Open AccessObjective Exercise Outcomes During GLP-1 Based Therapy: Distinguishing Cardiorespiratory Fitness from Walking Capacity. A Narrative Review
Background. Glucagon-like peptide-1 (GLP-1) receptor agonists and related incretin-based therapies can produce substantial weight loss and metabolic benefits. Their effects on objective exercise outcomes are less clear because studies use non-interchangeable endpoints ranging from directly measured oxygen uptake (VO₂) to walking distance. Objective. To summarize objective exercise outcomes during GLP-1-based therapy and separate directly measured cardiorespiratory fitness from changes observed with exercise training and from disease-specific walking capacity. Methods. We searched PubMed and tracked relevant citations up to July 2026. Adult clinical studies reporting at least one objective exercise outcome were grouped by outcome domain. Results. Ten clinical studies were included. In the 193-participant secondary analysis, liraglutide alone did not improve VO₂-derived fitness or physical-performance outcomes. Two smaller trials of exenatide or liraglutide without structured exercise were also neutral. VO₂ improved when structured exercise was included, but comparisons with matched exercise did not establish a clear additive drug effect. Walking outcomes improved most clearly in peripheral artery disease, whereas coronary artery disease and ischemia-focused endpoints were neutral. During substantial weight loss, body-mass-normalized VO₂ may rise partly because body mass in the denominator falls; absolute VO₂, VO₂ normalized to fat-free mass, workload, strength, and body composition therefore require separate interpretation. Conclusions.The meaning of an objective exercise outcome depends on what was measured. Current evidence does not consistently show an independent improvement in directly measured cardiorespiratory fitness with pharmacotherapy alone. Structured exercise remains the best-supported context for improving aerobic fitness. Disease-specific gains in walking capacity should not be interpreted as generalized cardiorespiratory-fitness gains.
- Open Access
- 24 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 76123
Swimming-Induced Pulmonary Edema in Open-Water Sports: Implications for Athlete Health and Event Medical Care — A Narrative Review
Background: Swimming-induced pulmonary edema (SIPE) is an uncommon but potentially serious complication of open-water swimming and triathlon. For event medical teams, the challenge extends beyond diagnosis to safe extraction, race-side assessment, respiratory support, and decisions about transfer or discharge.Objective: To review the clinical, physiological, and event-medicine literature on SIPE and develop a practical framework for medical care at mass-participation open-water events.Methods: We searched PubMed/MEDLINE and supplemented the search with Google Scholar, Semantic Scholar, Crossref, publisher websites, and citation tracking. Because the review was intended to inform event medicine, studies conducted in mass-participation settings were given greatest weight, with military, diving, physiological, and other clinical literature used when directly relevant.Results: Direct event evidence is concentrated in a small number of overlapping Vansbro cohorts. In symptomatic swimmers, pulse oximetry and auscultation performed well against LUS-confirmed pulmonary edema; at one low-altitude event, SpO₂ ≤95% or crackles gave 97% sensitivity and 86% specificity. These figures are specific to that setting. Lung ultrasound can add useful information, particularly because edema may be focal or anterior. CPAP and PEP have both been used on site with clinical improvement in observational data, but the available observational data do not establish comparative effectiveness. Crackles and B-lines may persist after symptoms and oxygenation improve. Severe, atypical, or non-resolving presentations require escalation.Conclusions: The literature supports a coherent sequence of event care: preparation, recognition, extraction, assessment, supportive treatment, reassessment, and a decision between escalation and stable disposition, followed by handover and follow-up. The framework proposed here is intended as a practical aid for local adaptation, not as a validated clinical protocol.
- 24 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 76, 76123
Open AccessSwimming-Induced Pulmonary Edema in Open-Water Sports: Implications for Athlete Health and Event Medical Care — A Narrative Review
Background: Swimming-induced pulmonary edema (SIPE) is an uncommon but potentially serious complication of open-water swimming and triathlon. For event medical teams, the challenge extends beyond diagnosis to safe extraction, race-side assessment, respiratory support, and decisions about transfer or discharge.Objective: To review the clinical, physiological, and event-medicine literature on SIPE and develop a practical framework for medical care at mass-participation open-water events.Methods: We searched PubMed/MEDLINE and supplemented the search with Google Scholar, Semantic Scholar, Crossref, publisher websites, and citation tracking. Because the review was intended to inform event medicine, studies conducted in mass-participation settings were given greatest weight, with military, diving, physiological, and other clinical literature used when directly relevant.Results: Direct event evidence is concentrated in a small number of overlapping Vansbro cohorts. In symptomatic swimmers, pulse oximetry and auscultation performed well against LUS-confirmed pulmonary edema; at one low-altitude event, SpO₂ ≤95% or crackles gave 97% sensitivity and 86% specificity. These figures are specific to that setting. Lung ultrasound can add useful information, particularly because edema may be focal or anterior. CPAP and PEP have both been used on site with clinical improvement in observational data, but the available observational data do not establish comparative effectiveness. Crackles and B-lines may persist after symptoms and oxygenation improve. Severe, atypical, or non-resolving presentations require escalation.Conclusions: The literature supports a coherent sequence of event care: preparation, recognition, extraction, assessment, supportive treatment, reassessment, and a decision between escalation and stable disposition, followed by handover and follow-up. The framework proposed here is intended as a practical aid for local adaptation, not as a validated clinical protocol.
- Open Access
- 23 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70, 74643
Targeted Cervicovestibular Rehabilitation for Persistent Symptoms After Sport-Related Concussion: A Narrative Review
Background: Sport-related concussion (SRC) usually resolves within the expected window, but a subgroup of athletes develops persistent symptoms that delay return-to-play (RTP), possibly reflecting overlapping cervical, vestibular, and vestibulo-ocular contributors rather than one post-concussion syndrome. Aim: To synthesize evidence on cervical, vestibular, and vestibulo-ocular dysfunction after SRC, with emphasis on persistent symptoms, targeted rehabilitation, and RTP. Material and methods: A structured PubMed search identified literature on SRC, persistent symptoms, cervical and vestibulo-ocular dysfunction, and rehabilitation. Full texts were narratively stratified; no pooling or risk-of-bias assessment was performed. Results: Cervical, vestibular, and vestibulo-ocular findings are clinically relevant in athletes with delayed recovery and are associated with persistent symptoms in observational studies. One small randomized trial supports combined cervical-vestibular physiotherapy in youth with persistent dizziness, neck pain, or headache; retrospective data suggest earlier vestibular therapy may shorten recovery, though causality remains unproven. Conclusions: Persistent symptoms after SRC warrant structured reassessment of cervical, vestibular, vestibulo-ocular, balance, and exertional domains. Targeted cervicovestibular rehabilitation appears promising; prospective trials are needed to define referral criteria, timing, sequencing, and RTP criteria.
- 23 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 70, 74643
Open AccessTargeted Cervicovestibular Rehabilitation for Persistent Symptoms After Sport-Related Concussion: A Narrative Review
Background: Sport-related concussion (SRC) usually resolves within the expected window, but a subgroup of athletes develops persistent symptoms that delay return-to-play (RTP), possibly reflecting overlapping cervical, vestibular, and vestibulo-ocular contributors rather than one post-concussion syndrome. Aim: To synthesize evidence on cervical, vestibular, and vestibulo-ocular dysfunction after SRC, with emphasis on persistent symptoms, targeted rehabilitation, and RTP. Material and methods: A structured PubMed search identified literature on SRC, persistent symptoms, cervical and vestibulo-ocular dysfunction, and rehabilitation. Full texts were narratively stratified; no pooling or risk-of-bias assessment was performed. Results: Cervical, vestibular, and vestibulo-ocular findings are clinically relevant in athletes with delayed recovery and are associated with persistent symptoms in observational studies. One small randomized trial supports combined cervical-vestibular physiotherapy in youth with persistent dizziness, neck pain, or headache; retrospective data suggest earlier vestibular therapy may shorten recovery, though causality remains unproven. Conclusions: Persistent symptoms after SRC warrant structured reassessment of cervical, vestibular, vestibulo-ocular, balance, and exertional domains. Targeted cervicovestibular rehabilitation appears promising; prospective trials are needed to define referral criteria, timing, sequencing, and RTP criteria.
- Open Access
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Beyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- 13 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 57, 72608
Open AccessBeyond the HPG Axis in Relative Energy Deficiency in Sport: Sleep, Psychological Health, and Neuroendocrine Adaptation in Athletes — A Structured Narrative Review
Background: Relative Energy Deficiency in Sport (REDs) is increasingly viewed as a multisystem condition related to problematic low energy availability (LEA), but evidence beyond reproductive and skeletal outcomes is uneven. Objective: To synthesize evidence on sleep, psychological health and neuroendocrine adaptation in athletes with LEA/REDs, while distinguishing established mechanisms from emerging domains. Methods: A structured narrative review with evidence mapping was conducted in PubMed/MEDLINE; 61 full-text records were assessed and synthesized across predefined domains. Findings: The strongest support concerns endocrine and metabolic adaptation, including thyroid, adipokine, somatotropic and stress-axis pathways, although individual markers remain non-specific. Sleep and psychological outcomes are clinically relevant but rely mainly on heterogeneous, mostly observational evidence. Direct neurocognitive evidence in athletes with well-characterized LEA/REDs remains insufficient. Conclusions: REDs should be considered beyond an HPG-centered framework, but claims regarding sleep, psychological health and neurocognition require caution. Future studies should combine objective LEA characterization, longitudinal designs, endocrine profiling, sleep assessment and direct cognitive testing.
- Open Access
- 14 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55, 70627
Comprehensive Non-Pharmacological Management of Rheumatoid Arthritis: A Multidisciplinary Approach
Background. Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint destruction, chronic pain, and significant functional impairment. While pharmacological treatment remains the cornerstone of therapy, it is increasingly recognized that optimal patient outcomes require a holistic approach. Non-pharmacological interventions are essential to address the physical, psychological, and social challenges faced by patients. Aim. The aim of this study is to evaluate the effectiveness of various non-pharmacological strategies in the management of RA and to highlight the importance of a coordinated, multidisciplinary team in improving patient quality of life and functional status. Material and methods. A comprehensive review of current clinical guidelines and recent literature (from databases such as PubMed and Scopus) was conducted. The analysis focused on interventions including physical therapy, occupational therapy, nutritional counseling, psychological support, and patient education programs within a multidisciplinary framework. Results. The findings indicate that regular aerobic and resistance exercise, combined with joint protection techniques, significantly reduce pain and fatigue while improving joint mobility. Dietary interventions (e.g., Mediterranean diet) and psychological interventions (e.g., Cognitive Behavioral Therapy) contribute to better disease control and mental well-being. A multidisciplinary approach, involving rheumatologists, physiotherapists, dietitians, and psychologists, leads to higher treatment adherence and better functional outcomes compared to monodisciplinary care. Conclusions. Non-pharmacological management is a vital component of RA care that complements medical treatment. A well-structured, multidisciplinary approach ensures personalized care, targets diverse symptoms, and empowers patients to manage their condition effectively, ultimately leading to a better quality of life.
- 14 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 55, 70627
Open AccessComprehensive Non-Pharmacological Management of Rheumatoid Arthritis: A Multidisciplinary Approach
Background. Rheumatoid arthritis (RA) is a chronic autoimmune disease that leads to joint destruction, chronic pain, and significant functional impairment. While pharmacological treatment remains the cornerstone of therapy, it is increasingly recognized that optimal patient outcomes require a holistic approach. Non-pharmacological interventions are essential to address the physical, psychological, and social challenges faced by patients. Aim. The aim of this study is to evaluate the effectiveness of various non-pharmacological strategies in the management of RA and to highlight the importance of a coordinated, multidisciplinary team in improving patient quality of life and functional status. Material and methods. A comprehensive review of current clinical guidelines and recent literature (from databases such as PubMed and Scopus) was conducted. The analysis focused on interventions including physical therapy, occupational therapy, nutritional counseling, psychological support, and patient education programs within a multidisciplinary framework. Results. The findings indicate that regular aerobic and resistance exercise, combined with joint protection techniques, significantly reduce pain and fatigue while improving joint mobility. Dietary interventions (e.g., Mediterranean diet) and psychological interventions (e.g., Cognitive Behavioral Therapy) contribute to better disease control and mental well-being. A multidisciplinary approach, involving rheumatologists, physiotherapists, dietitians, and psychologists, leads to higher treatment adherence and better functional outcomes compared to monodisciplinary care. Conclusions. Non-pharmacological management is a vital component of RA care that complements medical treatment. A well-structured, multidisciplinary approach ensures personalized care, targets diverse symptoms, and empowers patients to manage their condition effectively, ultimately leading to a better quality of life.